Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
28 February, 2020 23:51 IST
Zydus Cadila receives USFDA approval for Rivastigmine Transdermal system
Source: IRIS | 05 Mar, 2019, 04.15PM
Comments  |  Post Comment

Zydus Cadila has received the approval from the USFDA to market Rivastigmine Transdermal System (US RLD - EXELON PATCH), 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, marking its first approval for a transdermal product in the US. It is indicated for the treatment of dementia (memory loss) associated with Alzheimer’s and Parkinson’s diseases.

It will be manufactured at Zydus Technologies, the group’s manufacturing facility dedicated to the production of transdermals, located at SEZ, Ahmedabad.

The group also received the final approval for Rosuvastatin Tablets USP (US RLD ��" Crestor) in the strengths of 5 mg, 10 mg, 20 mg, and 40 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

Rosuvastatin belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood.

The group now has 252 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company gained Rs 7.8, or 2.41%, to settle at Rs 331.00. The total volume of shares traded was 98,061 at the BSE (Tuesday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
DIC India to sell Mumbai land for Rs 1.53 bn to Godrej Properties - 28-Feb-2020 16:51
DIC India to sell Mumbai land for Rs 1.53 bn to Godrej Properties - 28-Feb-2020 16:51
Pidilite Industries to acquire 70% stake in Tenax India - 28-Feb-2020 16:43
ONGC, Hindustan Petroleum buy 17.28% stake each in Petronet MHB - 28-Feb-2020 16:30
ONGC, Hindustan Petroleum buy 17.28% stake each in Petronet MHB - 28-Feb-2020 16:30
Suzlon Energy board approves proposal for restructuring of debt of Co - 28-Feb-2020 16:19
SC orders JP Associates to return to return pledged land to Jaypee - 27-Feb-2020 18:12
Thomas Cook India board approves buy-back of shares worth Rs 1.50 bn - 27-Feb-2020 18:07
TCS ranked no 1 in HFS Top 10 Retail and CPG Services report - 27-Feb-2020 17:56
CONCOR, Joint Stock Co of Russia ink MoU to promote cargo over INSTC - 27-Feb-2020 17:48
Adani Ports and Special Economic Zone incorporates overseas subsidiary - 27-Feb-2020 17:42
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer